Department | Validation/Technical Services | Document no | VAL-155 | ||
Prepared by: | Date: | Supersedes: | |||
Checked by: | Date: | Date Issued: | |||
Approved by: | Date: | Review Date: |
1.0 DOCUMENT OWNER
Validation / Technical Services Manager
2.0 PURPOSE
This SOP is to provide guidelines to ensure that materials that are brought into the manufacturing plant for trial purposes and not recorded into Material database are still accompanied by documentation so that their usage is recorded and reconciled and equipment that they contact is also recorded.
3.0 SCOPE
This SOP applies to all material trials conducted at the GMP site.
4.0 RESPONSIBILITY \ BUSINESS RULES
4.1 This SOP must be followed for all trials conducted in the Site plant.
Responsibility of: Validation / Technical Services, Quality Assurance, Manufacturing, Warehouse, Engineering.
4.2 Material Status
All materials used for trials must meet current GMP guidelines. Materials must be marked with a purple ‘Evaluation’ sticker available from the receiving office in the Warehouse or from Quality Assurance Staffs.
4.3 Segregation from Production Materials
All materials used in trials must be kept separate from production materials. The trial material must be stored in Quarantine Hold or in the Reject area when finished with, and must not enter the Pharmacy store with passed status material.
Responsibility of: Validation / Technical Services, Quality Assurance or Manufacturing.
5.0 PROCEDURE
5.1 Overview
Trials take place in the manufacturing plant using non-standard raw materials or packaging materials; sometimes even pilot products or products from other sites in and out of Site can be involved in trials. It is required that the movements of these materials in the plant is tracked and this procedure is to ensure that relevant documentation is created to accompany these materials in the plant.
5.2 Trials Using Raw Materials, Compounding Ingredients, Packaging Materials or Bulk Dosage Form for Core, Liquids and Packaging Areas.
As soon as it is known that the above materials are going to be arriving for a trial in the manufacturing area, a Manufacturing Instruction (MI) document or Packaging Instruction (PI) is to be raised using a Document Creation or Change Request form (Form-505).
The MI or PI should be marked with the letters “Packaging Trial” as part of the description of the job.
The following sections 5.2.1 to 5.2.7 apply to the MI and PI:
5.2.1 Lot Numbers and Identification
Must contain the producer’s lot numbers and the name of the source of the material or in house materials so that they can be identified. As much as possible of the supplied identification for the material is to be recorded to enable tracking of the details of the material. A batch number based on the format “8SBXX” where XX is a 2 digit sequential number is issued to the trial. This also separates the trial product from the batch numbers used for release for sale products.
5.2.2 Safety
Must contain the appropriate safety instructions; this can include MSDS information that could accompany the material.
5.2.3 Instructions
Must contain detailed instructions of how the material is to be handled and in what machinery and equipment it will be used.
5.2.4 Protocols
If a Process Qualification or Trial Protocol is involved with the work it is to be referenced
5.2.5 Cleaning
Procedures for recording machine cleanliness and readiness are to be followed, so there is a record of machine usage that can be related to the next product the machinery is used for.
5.2.6 Disposal
Once the trial is complete the disposal of the material should be recorded, for example “Moved to reject area of warehouse”.
5.2.7 Document Storage
Completed documents are to be stored with all other MI’s and PIs in the Quality Assurance Department filing system from where it can be retrieved if needed later.
5.2.8 Bulk/Placebo Trial Materials and Bulk Capsules
All bulk quantities of trial material must be stored in Quarantine Hold.
5.2.9 Notification of Planning / Commercial
Production and Commercial should be notified of the impending trial so that they can allow for its impact on production capacity.
5.2.10 Impact on Cleaning Validation Status
Any new excipients or API’s need to be evaluated for their impact on the cleaning validation status of equipment or process trains in the plant. Consultation with Technical Services or a specialist in cleaning validation will enable evaluation of the new materials against the Cleaning Validation Plan to determine if the new materials are a worst case for the equipment involved. A brief assessment report of this can be the documentation to show that this has been taken into account.
5.2.11 Non Standard Testing in QC Laboratory
Trial process will often result in samples to be tested by the QC Laboratory. A QC Laboratory Analytical Testing Report for Non Standard Testing form (Form-715) must be provided to the Laboratory Manager. A copy of the relevant part of the protocol controlling the trial attached to the Non Standard Testing form (Form-715) will assist the Laboratory to know what is required.
5.3 General Items Applicable to Packaging and Manufacturing Trials Documents
Once the trial is complete, a reconciliation is to be calculated and recorded on the appropriate form with the MI or PI. When the trial is finished the materials are to be moved to the reject area and disposed of according to the appropriate SOP and guidelines.
6.0 DEFINITIONS / ACRONYMS
None
7.0 REFERENCES
Form 505 | Document Creation or Change Request form |
Form 715 | Laboratory Analytical Testing Report for Non Standard Testing form |
8.0 SUMMARY OF CHANGES
Version # | Revision History |
VAL 155 | New |